Holen Sie sich die Stockscreener-App
1.58
7.48%
0.11
Vorhandelsmarkt:
1.61
0.03
+1.90%
Schlusskurs vom Vortag:
$1.47
Offen:
$1.51
24-Stunden-Volumen:
113.40K
Relative Volume:
0.38
Marktkapitalisierung:
$158.12M
Einnahmen:
$17.85M
Nettoeinkommen (Verlust:
$-96.93M
KGV:
-0.6388
EPS:
-2.4735
Netto-Cashflow:
$-88.29M
1W Leistung:
+8.22%
1M Leistung:
-7.60%
6M Leistung:
-65.95%
1J Leistung:
-78.71%
1-Tages-Spanne:
$1.50
$1.59
1-Wochen-Bereich:
$1.30
$1.59
52-Wochen-Spanne:
$1.26
$8.5878
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
1.58 | 140.10M | 17.85M | -96.93M | -88.29M | -2.4735 |
ISRG
Intuitive Surgical Inc
|
393.38 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.63 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.63 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.05 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.81 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah management to discuss Q2 results in Aug. 5 webcast - Stock Titan
Nyxoah SA (NYXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nyxoah SA (NYXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nyxoah SA (NYXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nyxoah SA (NYXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NYXH|Nyxoah SA|Price:1.400|Chg%:-0.070 - TradingKey
Nyxoah SA (NYXH) Cash Flow - TradingKey
Nyxoah SA Revenue Breakdown – FWB:5YI - TradingView
Nyxoah (NYXH) Q1 2026 Earnings: EPS Beat Narrowes Losses, Shares Dip as Market Awaits Revenue MilestonesManagement Guidance Update - dars.gov.et
Nyxoah SA (NYXH) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Nyxoah SA Revenue Breakdown – AQUISEU:NYXHB - TradingView
Nyxoah SA (NYXH) Stock Price Quote Today & Current Price Chart - Capital.com
Nyxoah SA (NYXH) Share Price Quote Today & Current Price Chart | Capital.com UK - Capital.com
Nyxoah SA (NYXH) Stock Price Quote Today & Current Price Chart | Capital.com EU - Capital.com
Nyxoah SA (NYXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Price to sales forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Discipline and Rules-Based Execution in NYXH Response - Stock Traders Daily
Price to sales forward of Nyxoah SA – FWB:5YI - TradingView
Nyxoah (NYXH) Slips Slightly as Stock Tests Key Support at $1.46Breadth Thrust - dars.gov.et
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $2.85 - 富途牛牛
Nyxoah (NYXH) Q1 2025 earnings summary - Quartr
Nyxoah Shares Slide Over 4% as Stock Approaches Key Support LevelMFI Oversold - dars.gov.et
Nyxoah (NYXH) Q1 2026 Earnings: Smaller-Than-Expected Loss Surprises but Stock DeclinesEPS Growth Rate - dars.gov.et
Nyxoah touts Genio US launch traction, reimbursement stability at investor day - MSN
Price to sales forward of Nyxoah SA – SWB:5YI - TradingView
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day - Yahoo Finance
Nyxoah (NASDAQ: NYXH) posts Q2 2026 prelims, secures $110M and sees CMS propose higher Genio reimbursement - Stock Titan
Stifel reiterates Hold on Nyxoah stock, keeps $3 price target By Investing.com - Investing.com India
Price to earnings forward of Nyxoah SA – SWB:5YI - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Stifel reiterates Hold on Nyxoah stock, keeps $3 price target - Investing.com
Nyxoah reports Q2 2026 preliminary revenue of €7.7M - MSN
Stifel maintains Hold on Nyxoah stock, cites cash flow concerns By Investing.com - Investing.com Nigeria
Nyxoah preliminary net revenue up 21% to €7.7M in Q2 2026 - Medical Buyer
Stifel maintains Hold on Nyxoah stock, cites cash flow concerns - Investing.com
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution - Yahoo Finance
Nyxoah (NYXH) Reports Strong Momentum and Financial Progress in Q2 - GuruFocus
Nyxoah Rides U.S. Momentum and CMS Boost in Strong Q2 Preliminary Results - TipRanks
Revenue Expectations for NYXH Set Between EUR 36 Million and EUR 40 Million - GuruFocus
Nyxoah Backs FY26 Rev EUR36M-EUR40M >NYXH.BT - Moomoo
Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed - Moomoo
Nyxoah sees Q2 revenue EUR 7.7M - TipRanks
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 - The Manila Times
Nyxoah (NYXH) Dips 3.37% as Shares Test Key Support ZoneIceberg Order - dars.gov.et
NYXHNyxoah SA Latest SEC Filings - Finviz
Invitation to Attend the Extraordinary Shareholders' Meeting of the Company to Be Held on July 9, 2026 - 富途牛牛
ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah — 1.94M shares - Stock Titan
Information on the total number of voting rights and shares - GlobeNewswire
Behavioral Patterns of NYXH and Institutional Flows - Stock Traders Daily
Price to book forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Enterprise value to EBITDA forward of Nyxoah SA – EURONEXT:NYXH - TradingView
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.37%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):